These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2556174)

  • 1. Comparative intragastric pH profile of Algicon versus Gaviscon.
    Stoddard CJ; Morgan GE
    Br J Clin Pract Suppl; 1989 Feb; 66():29-34; discussion 35-6. PubMed ID: 2556174
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastric pH and endoscopic appearance after Algicon administration.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():25-8; discussion 35-6. PubMed ID: 2511920
    [No Abstract]   [Full Text] [Related]  

  • 3. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
    Vatier J; Vitre MT; Vallot T; Mignon M
    Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
    Ward AE
    Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
    Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
    Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
    [No Abstract]   [Full Text] [Related]  

  • 6. Algicon in the management of gastro-oesophageal reflux.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
    [No Abstract]   [Full Text] [Related]  

  • 7. The mode of action alginic acid compound in the reduction of gastroesophageal reflux.
    Malmud LS; Charkes ND; Littlefield J; Reilley J; Stern H; Rosenberg R; Fisher RS
    J Nucl Med; 1979 Oct; 20(10):1023-8. PubMed ID: 231639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioavailability of orally administered iron. Effects of alginate/antacid administration].
    Campo S; Breda E
    Minerva Med; 1992 Mar; 83(3):145-7. PubMed ID: 1553063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
    Guerre J; Neuman M; Bouchet J
    Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro studies of antacids. I].
    Schnekenburger J
    Arzneimittelforschung; 1974 Feb; 24(2):142-4. PubMed ID: 4406362
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vivo anti-reflux and raft properties of alginates.
    Lambert JR; Korman MG; Nicholson L; Chan JG
    Aliment Pharmacol Ther; 1990 Dec; 4(6):615-22. PubMed ID: 2129648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.
    Washington N; Greaves JL; Iftikhar SY
    Aliment Pharmacol Ther; 1992 Oct; 6(5):579-88. PubMed ID: 1420749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
    Mandel KG; Daggy BP; Brodie DA; Jacoby HI
    Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gaviscon].
    Ménégol-Couque B; Brard M
    Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemico-physical property and bile acid binding capacity of several antacids].
    Salvioli G; Tambara E; Gaetti E; Lugli R
    Minerva Dietol Gastroenterol; 1989; 35(2):79-83. PubMed ID: 2548124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of antacids on mineral metabolism in persons with healthy kidneys. Double-blind study using an antacid containing magnesium aluminum silicate hydrate].
    Herzog P; Holtermüller KH
    MMW Munch Med Wochenschr; 1982 Oct; 124(42):921-3. PubMed ID: 6298611
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.
    Lang GD; Dougall A
    Br J Clin Pract Suppl; 1989 Feb; 66():48-51; discussion 61-4. PubMed ID: 2556175
    [No Abstract]   [Full Text] [Related]  

  • 18. The mode of action and complications of Infant Gaviscon.
    Keipert JA
    Aust Paediatr J; 1979 Dec; 15(4):263-5. PubMed ID: 44677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gastroesophageal reflux. Results of a multicenter study of 170 patients on the therapeutic value of the Gaviscon drinkable suspension].
    Chevrel B
    Med Chir Dig; 1980; 9(6):535-9. PubMed ID: 6259459
    [No Abstract]   [Full Text] [Related]  

  • 20. Gaviscon bezoars.
    Sorbie AL; Symon DN; Stockdale EJ
    Arch Dis Child; 1984 Sep; 59(9):905-6. PubMed ID: 6091569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.